Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: Essential role in fatty acid oxidation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 3, 2006, Pages

  Bezaire, Veronic ^a   Bruce, Clinton R ^a   Heigenhauser, George J F ^b   Tandon, Narendra N ^c   Glatz, Jan F C ^d   Luiken, Joost J J F ^d   Bonen, Arend ^a   Spriet, Lawrence L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Otsuka Maryland Medicinal Laboratories   (Canada)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fatty acid translocase; Long chain fatty acid

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; CYTOCHROME C OXIDASE; LONG CHAIN FATTY ACID; OCTANOIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOYLCARNITINE; SULFO N SUCCIMIDYL OLEIC ACID; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FATTY ACID TRANSPORTER; OCTANOIC ACID DERIVATIVE; SUCCINIMIDE DERIVATIVE; SULFO N SUCCINIMIDYL OLEATE; SULFO-N-SUCCINIMIDYL OLEATE;

ADULT; AEROBIC EXERCISE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKELETAL MUSCLE; WESTERN BLOTTING; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; MITOCHONDRIAL MEMBRANE; OXIDATION REDUCTION REACTION;

ADULT; BLOTTING, WESTERN; CARNITINE O-PALMITOYLTRANSFERASE; ENZYME INHIBITORS; FATTY ACID TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL MEMBRANES; MUSCLE, SKELETAL; OCTANOIC ACIDS; OLEIC ACIDS; OXIDATION-REDUCTION; PALMITIC ACID; SUCCINIMIDES;

EID: 33645082002     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00312.2005     Document Type: Article

References (54)

1. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, and Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665-17668, 1993.
2. Bach AC and Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 36: 950-962, 1982.
3. Benz R. Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. Biochim Biophys Acta 1197: 167-196, 1994.
4. Bergmeyer HU. Methods in Enzymatic Analysis. New York: Weinheim Verlag Chemie, 1974.
5. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609-616, 1975.
6. Berthon PM, Howlett RA, Heigenhauser GJ, and Spriet LL. Human skeletal muscle carnitine palmitoyltransferase I activity determined in isolated intact mitochondria. J Appl Physiol 85: 148-153, 1998.
7. Bezaire V, Heigenhauser GJ, and Spriet LL. Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle. Am J Physiol Endocrinol Metab 286: E85-E91, 2004.
8. Bonen A, Luiken JJ, Arumugam Y, Glatz JF, and Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275: 14501-14508, 2000.
9. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ, and Dyck DJ. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18: 1144-1146, 2004.
10. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, and Hawley JA. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88: 5444-5451, 2003.
11. Cameron-Smith D, Burke LM, Angus DJ, Tunstall RJ, Cox GR, Bonen A, Hawley JA, and Hargreaves M. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am J Clin Nutr 77: 313-318, 2003.
12. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, and Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279: 36235-36241, 2004.
13. Carter SL, Rennie CD, Hamilton SJ, and Tarnopolsky. Changes in skeletal muscle in males and females following endurance training. Can J Physiol Pharmacol 79: 386-392, 2001.
14. Coort SL, Willems J, Coumans WA, van der Vusse GJ, Bonen A, Glatz JF, and Luiken JJ. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem 239: 213-219, 2002.
15. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, and Bouck NP. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 138: 707-717, 1997.
16. Dean D, Daugaard JR, Young ME, Saha A, Vavvas D, Asp S, Kiens B, Kim KH, Witters L, Richter EA, and Ruderman N. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 49: 1295-1300, 2000.
17. Duttaroy AK and Spener F. Cellular Proteins and Their Fatty Acids in Health and Disease. Cambridge, UK: Wiley-VCH, 2003.
18. Eaton S. Control of mitochondrial beta-oxidation flux. Prog Lipid Res 41: 197-239, 2002.
19. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, and Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816, 1993.
20. Esser V, Brown NF, Cowan AT, Foster DW, and McGarry JD. Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform expressed in both white (epididymal) and brown adipocytes. J Biol Chem 271: 6972-6977, 1996.
21. Fraser F, Corstorphine CG, and Zammit VA. Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane. Biochem J 323: 711-718, 1997.
22. Greenwalt DE, Watt KW, So OY, and Jiwani N. PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GP IV). Biochemistry 29: 7054-7059, 1990.
23. Harmon CM and Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 133: 43-49, 1993.
24. James G and Olson EN. Fatty acylated proteins as components of intracellular signaling pathways. Biochemistry 29: 2623-2634, 1990.
25. Jochen A and Hays J. Purification of the major substrate for palmitoylation in rat adipocytes: N-terminal homology with CD36 and evidence for cell surface acylation. J Lipid Res 34: 1783-1792, 1993.
26. Jong-Yeon K, Hickner RC, Dohm GL, and Houmard JA. Long- and medium-chain fatty acid oxidation is increased in exercise-trained human skeletal muscle. Metabolism 51: 460-464, 2002.
27. Keizer H, Schaart G, Tandon N, Glatz J, and Luiken J. Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem Cell Biol 121: 101-107, 2004.
28. Kerner J and Hoppel C. Fatty acid import into mitochondria. Biochim Biophys Acta 1486: 1-17, 2000.
29. Kiens B, Roepstorff C, Glatz JF, Bonen A, Schjerling P, Knudsen J, and Nielsen JN. Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol 97: 1209-1218, 2004.
30. Kim JY, Koves TR, Yu GS, Gulick T, Cortright RN, Dohm GL, and Muoio DM. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 282: E1014-E1022, 2002.
31. Luiken JJ, Dyck DJ, Han XX, Tandon NN, Arumugam Y, Glatz JF, and Bonen A. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol Endocrinol Metab 282: E491-E495, 2002.
32. Luiken JJ, Schaap FG, van Nieuwenhoven FA, van der Vusse GJ, Bonen A, and Glatz JF. Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins. Lipids Suppl 34: S169-S175, 1999.
33. Luiken JJ, Turcotte LP, and Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 40: 1007-1016, 1999.
34. Matsuno K, Diaz-Ricart M, Montgomery RR, Aster RH, Jamieson GA, and Tandon NN. Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol 92: 960-967, 1996.
35. McGarry JD and Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244: 1-14, 1997.
36. McGarry JD, Mills SE, Long CS, and Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28, 1983.
37. Odland LM, Heigenhauser GJ, Lopaschuk GD, and Spriet LL. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am J Physiol Endocrinol Metab 270: E541-E544, 1996.
38. Odland LM, Howlett RA, Heigenhauser GJ, Hultman E, and Spriet LL. Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans. Am J Physiol Endocrinol Metab 274: E1080-E1085, 1998.
39. Pearce SF, Wu J, and Silverstein RL. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood 84: 384-389, 1994.
40. Rasmussen BB and Winder WW. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 83: 1104-1109, 1997.
41. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA, and Kiens B. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 288: E133-E142, 2005.
42. Roepstorff C, Helge J, Vistisen B, and Kiens B. Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscle. Proc Nutr Soc 63: 239-244, 2004.
43. Roepstorff C, Vistisen B, Roepstorff K, and Kiens B. Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 287: E696-E705, 2004.
44. Silverstein RL, Asch AS, and Nachman RL. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 84: 546-552, 1989.
45. Srere PA. Citrate synthase. In: Methods in Enzymology, edited by Lowenstein JM. New York: Academic, 1969 p. 3-5.
46. Starritt EC, Howlett RA, Heigenhauser GJ, and Spriet LL. Sensitivity of CPT I to malonyl-CoA in trained and untrained human skeletal muscle. Am J Physiol Endocrinol Metab 278: E462-E468, 2000.
47. Tanaka T and Kawamura K. Isolation of myocardial membrane long-chain fatty acid-binding protein: homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J Mol Cell Cardiol 27: 1613-1622, 1995.
48. Tandon NN, Kralisz U, and Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264: 7576-7583, 1989.
49. Tao N, Wagner SJ, and Lublin DM. CD36 is palmitoylated on both N-and C-terminal cytoplasmic tails. J Biol Chem 271: 22315-22320, 1996.
50. Tremblay A, Simoneau JA, and Bouchard C. Impact of exercise intensity on body fatness and skeletal muscle metabolism. Metabolism 43: 814-818, 1994.
51. Tunstall RJ, Mehan KA, Wadley GD, Collier GR, Bonen A, Hargreaves M, and Cameron-Smith D. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283: E66-E72, 2002.
52. Vistisen B, Roepstorff K, Roepstorff C, Bonen A, van Deurs B, and Kiens B. Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers. J Lipid Res 45: 603-609, 2004.
53. Winder WW, Arogyasami J, Barton RJ, Elayan IM, and Vehrs PR. Muscle malonyl-CoA decreases during exercise. J Appl Physiol 67: 2230-2233, 1989.
54. Winder WW, Arogyasami J, Elayan IM, and Cartmill D. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol Endocrinol Metab 259: E266-E271, 1990.